Text Search: Search by:

Refine your search with filters

Year:

All

Congress Abstracts

Tools & Skills

Publications

Congress Presentations

Videos & Podcasts

Quicksearch

P317: Health care costs associated with standard inflammatory bowel disease care in Australia and opportunities to improve care: a tertiary centre studyECCO '16 Amsterdam

Year: 2016

Authors:

B. Jackson*¹, R. Ma¹, A. Gorelik², D. Con¹, D. Liew², P. De Cruz¹

¹Austin Health, Gastroenterology, Melbourne, Australia, ²Melbourne Health, Melbourne, Australia

P318: Does anti-tumour necrosis factor therapy decrease the risk of initial intestinal resection after the diagnosis of Crohn’s disease? A retrospective single-centre studyECCO '16 Amsterdam

Year: 2016

Authors:

Y. Nagata*¹, M. Esaki¹, A. Hirano¹, J. Umeno¹, Y. Maehata¹, T. Torisu¹, T. Moriyama¹, T. Matsumoto², T. Kitazono¹

¹Graduate School of Medical Sciences, Kyushu University, Department of Medicine and Clinical Science, Fukuoka, Japan, ²School of Medicine, Iwate Medical University, Division of Gastroenterology, Department of Internal Medicine, Morioka, Japan

P319: Combining anti-inflammatory treatment with antiviral treatment in severe cytomegalovirus-positive ulcerative colitis does not affect colectomy rate: a retrospective European multicentre studyECCO '16 Amsterdam

Year: 2016

Authors:

U. Kopylov*¹, K. Papamichael^{2, 3}, K. Katsanos⁴, M. Waterman⁵, A. Bar-Gil Shitrit⁶, T. Boysen⁷, F. Portela⁸, A. Peixoto⁹, A. Szilagyi¹⁰, M. Silva⁹, G. Maconi¹¹, O. Har-Noy¹, P. Bossuyt¹², G. Mantzaris², M. Barreiro de Acosta¹³, M. Chaparro¹⁴, D. Christodoulou⁴, R. Eliakim¹, J.-F. Rahier¹⁵, F. Magro⁹, S. Ben-Horin¹⁶, X. Roblin¹⁷

¹Sheba Medical Centre, Gastroenterology, Tel Hashomer, Israel, ²Evaggelismos Hospital, Gastroenterology, Athens, Greece, ³KU Leuven, Department of Clinical and Experimental Medicine, Translational Research Centre for Gastrointestinal Disorders (TARGID), Leuven, Belgium, ⁴University of Ioannina, Gastroenterology, Ioannina, Greece, ⁵Rambam Healthcare Campus, Gastroenterology, Haifa, Israel, ⁶Shaare Zedek Medical Centre, Digestive diseases Institute, Jerusalem, Israel, ⁷Herlev University Hospital, Gastroenterology, Herlev, Denmark, ⁸Hospital Universidade Coimbra, Gastroenterology, Coimbra, Portugal, ⁹Centro Hospitalar São João, Gastroenterology, Porto, Portugal, ¹⁰Jewish General Hospital, Department of Gastroenterology, Montreal, Canada, ¹¹Luigi Sacco’ University Hospital, Gastroenterology, Milan, Italy, ¹²Imelda GI clinical research Centre,, Gastroenterology, Bonheiden, Belgium, ¹³University Hospital of Santiago de Compostela, IBD Unit, Gastroenterology Department, Santiago de Compostela, Spain, ¹⁴Hospital Universitario de La Princesa, Gastroenterology, Madrid, Spain, ¹⁵CHU Dinant Godinne, UCL Namur, Gastroenterology, Yvoir, Belgium, ¹⁶Chaim Sheba Medical Centre, Gastroenterology, Ramat Gan, Israel, ¹⁷CHU de Saint-Etienne, Gastroenterology, Saint-Etiennne, France

P320: Clinical and economic effect of short infliximab infusion protocol in patients with inflammatory bowel diseases: a multicentre studyECCO '16 Amsterdam

Year: 2016

Authors:

M. Cappello*¹, G. Costantino², A.C. Privitera³, F. Bossa⁴, A. Lauria⁵, L. Grossi⁶, M. B. Principi⁷, N. Della Valle⁸, M. A. Veneziano⁹, D. Crocchiolo⁹

¹University of Palermo, Gastroenterology Section, DiBiMis, Palermo, Italy, ²Università di Messina, Dipartimento di Medicina Interna e Terapia Medica, Messina, Italy, ³Azienda Ospedaliera per l’Emergenza, Ospedale Cannizzaro, Catania, Gastroenterologia, Catania, Italy, ⁴Casa Sollievo della Sofferenza, Gastroenterologia, S. Giovanni Rotondo, Foggia, Italy, ⁵A. O. Bianchi-Melacrino-Morelli, Reggio Calabria, Gastroenterologia e Endoscopia Digestiva, Reggio Calabria, Italy, ⁶Ospedale Spirito Santo, Pescara, Fisiopatologia Digestiva, Pescara, Italy, ⁷Policlinico, Department of Gastroenterology, Bari, Italy, ⁸Ospedale di Foggia, Gastroenterologia, Foggia, Italy, ⁹MSD Italy, Rome, Italy

P321: Mucosal healing in a cohort of inflammatory bowel diseases paediatric patients in clinical remissionECCO '16 Amsterdam

Year: 2016

Authors:

F. P. Giugliano¹, C. Strisciuglio*², M. Martinelli¹, M. Andreozzi¹, S. Cenni¹, A. Staiano¹, E. Miele¹

¹University Federico II, Department of Translational Medical Science, Section of Paediatrics, Naples, Italy, ²Second University of Naples, Department of Woman, Child and General and Specialised Surgery, Naples, Italy

P322: Complications to parenteral therapy in patients with intestinal failure because of inflammatory bowel disease: A retrospective cohort studyECCO '16 Amsterdam

Year: 2016

Authors:

R. Lorentsen, L. K. Munck, S. Wildt*

Køge University Hospital, and Faculty of Health Sciences, University of Copenhagen, Section of Gastroenterology, Medical Department, Køge, Denmark

P323: Prevalence of vitamin D deficiency in patients with inflammatory bowel diseaseECCO '16 Amsterdam

Year: 2016

Authors:

N. Toke*, P. Kakkadasam Ramaswamy, B. Sebastian, S. Mathai, C. Panackel

Medical Trust Hospital, Department of Gastroenterology, Ernakulam, India

P324: Comparative short and long-term efficacy of infliximab and adalimumab in patients with ulcerative colitis refractory to corticosteroids: a retrospective studyECCO '16 Amsterdam

Year: 2016

Authors:

N. Yoshimura*, M. Sako, M. Takazoe

Tokyo Yamate Medical Centre, Department of Internal Medicine, Tokyo, Japan

P325: Efficacy, safety, and long-term outcome of endoscopic dilation therapy for stricturing Crohn’s disease of the upper gastrointestinal tract: a combined analysis of 127 endoscopic balloon dilation proceduresECCO '16 Amsterdam

Year: 2016

Authors:

D. Bettenworth*¹, M. M. Mücke¹, A. Singh², R. Lopez³, F. Rieder^{4, 5}

¹University Hospital Münster, Department of Medicine B, Münster, Germany, ²Cleveland Clinic Foundation, Department of Hospital Medicine, Cleveland, Ohio, United States, ³Cleveland Clinic Foundation, Department of Quantitative Health Sciences, Cleveland, Ohio, United States, ⁴Cleveland Clinic Foundation, Department of Gastroenterology, Hepatology & Nutrition, Digestive Disease Institute, Cleveland, Ohio, United States, ⁵Cleveland Clinic Foundation, Department of Pathobiology, Cleveland, Ohio, United States

P326: Validation of CUCQ-8 Questionnaire for Quality of Life Assessment in IBD PatientsECCO '16 Amsterdam

Year: 2016

Authors:

C. McGinley*¹, C. Mowat², M. Groome², J. Todd², N. Reynolds²

¹University of Dundee, Dundee, United Kingdom, ²Ninewells Hospital and Medical School, Department of Gastroenterology, Dundee, United Kingdom

Year: 2016

Authors:

L. Carvalho Lourenço*, V. Anapaz, A. M. Oliveira, J. Branco, M. Cardoso, C. Graça Rodrigues, L. Santos, D. Horta, A. Martins, J. Reis

Hospital Prof Dr Fernando Fonseca, Serviço de Gastrenterologia, Amadora, Portugal

P328: Factors related to short- and long-term treatment results and usefulness of infliximab for refractory ulcerative colitisECCO '16 Amsterdam

Year: 2016

Authors:

Y. Takada*, S. Yasukawa, R. Amano, M. Yasaka, N. Takatsu, Y. Yano, F. Hirai

Fukukuoka University Chikushi hospital, Chikushino-shi, Japan

P329: Infliximab biosimilar in the treatment of inflammatory bowel disease: a Japanese single-cohort observational studyECCO '16 Amsterdam

Year: 2016

Authors:

S. Hamanaka*, T. Nakagawa, H. Koseki, T. Sakurai, T. Taida, K. Okimoto, K. Saito, D. Maruoka, T. Matsumura, T. Katsuno, M. Arai, O. Yokosuka

Graduate School of Medicine, Chiba University, Department of Gastroenterology and Nephrology, Chiba City, Japan

P330: Vitamin D insufficiency in patients with inflammatory bowel diseaseECCO '16 Amsterdam

Year: 2016

Authors:

M. d. C. Martos Plasencia*, C. Verdejo Gil, R. H. Lorente Poyatos, E. De la Santa Belda, M. Peña Gómez, R. Salmoral Luque, B. López Viedma, J. Olmedo Camacho

University Hospital of Ciudad Real, Gastroenterology and Hepatology Department, Ciudad Real, Spain

P331: Allopurinol and azathioprine co-therapy or thioguanine dose splitting: shifting the shunters in the mercaptopurine pathway in a paediatric inflammatory bowel disease population—a single-centre experienceECCO '16 Amsterdam

Year: 2016

Authors:

S. Chadokufa*¹, A. Lozinsky Rolnik², S. Sider¹, N. Acton³, B. Huggett³, N. Shah⁴, F. Kiparissi¹

¹Great Ormond Street Hospital, Gastro, London, United Kingdom, ²Great Ormond Street Hospital, Gastro, LONDON, United Kingdom, ³Great Ormond Street, London, United Kingdom, ⁴Great Ormond Street, Gastro, London, United Kingdom

P332: Influence of mesalamine maintenance therapy on progression of ulcerative proctitis in KoreaECCO '16 Amsterdam

Year: 2016

Authors:

Y. S. Choi¹, W. J. Kim*², H.-J. Jung³, J. K. Kim¹, K.-H. Song³

¹Daehang Hospital, Gastroenterology, Seoul, South Korea, ²Soonchunhyang University Hospital, Gastroenterology, Gumi-si, South Korea, ³Daehang Hospital, Surgery, Seoul, South Korea

P333: Long-term efficacy and safety of thiopurines in patients with steroid-dependent ulcerative colitis: a retrospective investigationECCO '16 Amsterdam

Year: 2016

Authors:

Y. Yokoyama*, T. Sato, M. Kawai, Y. Kita, K. Kamikozuru, T. Miyazaki, M. Iimuro, N. Hida, S. Nakamura

Hyogo College of Medicine, Department of Inflammatory Bowel Disease, Division of Internal Medicine, Nishinomiya, Japan

P334: Evolution of a long-term follow-up cohort of Crohn’s disease with complex perianal fistula: from antibiotic to combined AZA and anti-TNF based treatment ending up clinical and radiological healing with or without stomaECCO '16 Amsterdam

Year: 2016

Authors:

Y. Erzin*, K. Ercaliskan, I. Hatemi, K. Atay, S. Bozcan, N. Demir, A. F. Celik

Istanbul University Cerrahpasa Medical School, Gastroenterology, Istanbul, Turkey

P335: Cancer recurrence with immunosuppressive therapy in immune-mediated diseases: a systematic review and meta-analysisECCO '16 Amsterdam

Year: 2016

Authors:

E. Shelton*¹, D. Laharie², F. Scott³, R. Mamtani⁴, J. Lewis⁴, J.-F. Colombel⁵, A. Ananthakrishnan¹

¹Massachusetts General Hospital, Boston, Massachusetts, United States, ²University-Bordeaux, Bordeaux, France, ³University of Pennsylvania, Philadelphia, Pennsylvania, United States, ⁴University of Pennsylvania Perelman School of Medicine, Division of Gastroenterology, Philadelphia, Pennsylvania, United States, ⁵Mount Sinai, Icahn School of Medicine, New York, New York, United States

P336: French prospective, longitudinal observational study of the therapeutic management of mild to moderate ulcerative colitis (Optimum study): follow-up at 3 yearsECCO '16 Amsterdam

Year: 2016

Authors:

S. Nahon*¹, G. Bonnaud², F. Bahbah³

¹Centre Hospitalier Le Raincy, Montfermeil, France, ²Ambroise Paré Private hospital, IBD Unit, Toulouse, France, ³Ferring Pharmaceuticals, Gentilly, France